[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Collegium Pharma (COLL)

Collegium Pharma (COLL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 890,406
  • Shares Outstanding, K 32,556
  • Annual Sales, $ 780,570 K
  • Annual Income, $ 62,870 K
  • EBIT $ 157 M
  • EBITDA $ 382 M
  • 60-Month Beta 0.73
  • Price/Sales 1.13
  • Price/Cash Flow 1.78
  • Price/Book 2.82

Options Overview Details

View History
  • Implied Volatility 56.25% (-4.44%)
  • Historical Volatility 73.77%
  • IV Percentile 42%
  • IV Rank 35.33%
  • IV High 88.16% on 03/11/26
  • IV Low 38.82% on 02/18/26
  • Expected Move (DTE 24) 0.00 (0.00%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 89
  • Volume Avg (30-Day) 188
  • Put/Call OI Ratio 0.84
  • Today's Open Interest 901
  • Open Int (30-Day) 1,214
  • Expected Range 27.47 to 27.47

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $1.58
  • Number of Estimates 2
  • High Estimate $1.62
  • Low Estimate $1.53
  • Prior Year $2.06
  • Growth Rate Est. (year over year) -23.30%

Price Performance

See More
Period Period Low Period High Performance
1-Month
25.47 +7.85%
on 08/12/26
36.63 -25.02%
on 07/29/26
-7.73 (-21.96%)
since 07/24/26
3-Month
25.47 +7.85%
on 08/12/26
38.49 -28.64%
on 07/07/26
-6.60 (-19.37%)
since 05/22/26
52-Week
25.47 +7.85%
on 08/12/26
50.79 -45.91%
on 12/29/25
-11.30 (-29.15%)
since 08/25/25

Most Recent Stories

More News
Collegium Announces $50 Million Accelerated Share Repurchase Program

STOUGHTON, Mass., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading biopharmaceutical company focused on improving the lives of people living with serious and...

COLL : 27.47 (+0.44%)
5 Revealing Analyst Questions From Collegium Pharmaceutical’s Q2 Earnings Call

5 Revealing Analyst Questions From Collegium Pharmaceutical’s Q2 Earnings Call

COLL : 27.47 (+0.44%)
COLL Q2 Deep Dive: ADHD Expansion and Pain Business Headwinds Shape Guidance

COLL Q2 Deep Dive: ADHD Expansion and Pain Business Headwinds Shape Guidance

COLL : 27.47 (+0.44%)
Collegium Pharmaceutical (NASDAQ:COLL) Reports Sales Below Analyst Estimates In Q2 CY2026 Earnings, Stock Drops

Collegium Pharmaceutical (NASDAQ:COLL) Reports Sales Below Analyst Estimates In Q2 CY2026 Earnings, Stock Drops

COLL : 27.47 (+0.44%)
Collegium Pharmaceutical: Q2 Earnings Snapshot

Collegium Pharmaceutical: Q2 Earnings Snapshot

COLL : 27.47 (+0.44%)
Collegium Reports Second Quarter 2026 Financial Results and Highlights Recent Company Progress

– Completed Acquisition of AZSTARYS ® , Strengthening ADHD Portfolio and Extending Long-Term Revenue Outlook – – Generated Quarterly Net Revenues of $199.9 Million, Up 6% Year-over-Year...

COLL : 27.47 (+0.44%)
Collegium's Pain Portfolio Faces Its First Test Without Guidance

Barchart Research What to Expect from COLL Earnings COLL Generated August 5, 2026 Current Price $35.74 EPS Estimate $$1.48 Consensus Rating Moderate Buy Average Move 4.85% Collegium's Pain Portfolio Faces...

COLL : 27.47 (+0.44%)
Collegium Pharmaceutical (COLL) Reports Earnings Tomorrow: What To Expect

Collegium Pharmaceutical (COLL) Reports Earnings Tomorrow: What To Expect

COLL : 27.47 (+0.44%)
1 Cash-Producing Stock Worth Investigating and 2 We Ignore

1 Cash-Producing Stock Worth Investigating and 2 We Ignore

COLL : 27.47 (+0.44%)
GMED : 82.96 (-1.33%)
WOOF : 2.76 (-4.17%)
Winners And Losers Of Q1: Collegium Pharmaceutical (NASDAQ:COLL) Vs The Rest Of The Branded Pharmaceuticals Stocks

Winners And Losers Of Q1: Collegium Pharmaceutical (NASDAQ:COLL) Vs The Rest Of The Branded Pharmaceuticals Stocks

COLL : 27.47 (+0.44%)

Business Summary

Collegium Pharmaceutical Inc. is a specialty pharmaceutical company. It develops and commercializes prescription and over-the-counter pharmaceuticals for the treatment of central nervous system, respiratory and skin related disorders. The Company's product candidate consists of COL-195, COL-196, COL-171,...

See More

Key Turning Points

3rd Resistance Point 28.40
2nd Resistance Point 28.08
1st Resistance Point 27.77
Last Price 27.47
1st Support Level 27.15
2nd Support Level 26.83
3rd Support Level 26.52

See More

52-Week High 50.79
Fibonacci 61.8% 41.12
Fibonacci 50% 38.13
Fibonacci 38.2% 35.14
Last Price 27.47
52-Week Low 25.47

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.